Edgewise Therapeutics, Inc. (EWTX) Reports In-Line Q1 EPS

Edgewise Therapeutics, Inc. (NASDAQ: EWTX) reported Q1 EPS of ($0.43), in-line with the analyst estimate of ($0.43).

For earnings history and earnings-related data on Edgewise Therapeutics, Inc. (EWTX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Fiserv (FISV) PT Lowered to $60 at Freedom Broker
• Phillips 66, Marathon Merger Talks Collapsed - Semafor